LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Clinical trial NCT06103682 · RECRUITING

Trial details

NCT number: NCT06103682
Sponsor: University of California, Davis
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Oligoprogressive Small-cell Lung Cancer

Start date: 2023-10-05
Primary completion: 2029-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.